Loading organizations...
Primavera Capital Group is a premier Asia-Pacific investment firm, connecting global capital with leading regional companies. It identifies attractive opportunities, partnering with high-potential growth enterprises to foster entrepreneurship and innovation. This disciplined approach generates significant value for investors and portfolio companies, contributing to economic advancement.
Fred Hu, a distinguished economist, founded Primavera Capital in 2010. With degrees from Tsinghua and Harvard, Hu held key roles at the International Monetary Fund, World Economic Forum, and Goldman Sachs. This experience provided the essential insight to establish Primavera, bridging global finance with Asia-Pacific development.
The firm serves global investors seeking dynamic Asia-Pacific opportunities, building lasting partnerships with entrepreneurial growth companies. Primavera's vision cultivates robust enterprises achieving financial success and positive global contributions. It directs investment into sectors fostering innovation and sustainable growth.
Chuanhua Capital has 1 tracked investment across 1 company. The latest tracked deal is $52.0M Series A in Arnatar Therapeutics in August 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 25, 2025 | Arnatar Therapeutics | $52.0M Series A | 3E Bioventures Capital, Eight Roads Ventures | F Prime Capital, Gaorong Capital, Hongsheng Capital, NEW Alliance Capital, Yijing Capital |